Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Return on Assets (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Return on Assets over the past 9 years, most recently at 0.01% for Q4 2023.

  • For Q4 2023, Return on Assets fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2023 reached 0.01%, down 1.0%, while the annual FY2023 figure was 0.01%, 1.0% down from the prior year.
  • Return on Assets for Q4 2023 was 0.01% at Corbus Pharmaceuticals Holdings, down from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2022 and troughed at 0.01% in Q4 2023.
  • A 5-year average of 0.01% and a median of 0.01% in 2021 define the central range for Return on Assets.
  • Biggest five-year swings in Return on Assets: fell -1bps in 2020 and later grew 1bps in 2021.
  • Year by year, Return on Assets stood at 0.01% in 2019, then rose by 4bps to 0.01% in 2020, then soared by 60bps to 0.0% in 2021, then dropped by -15bps to 0.01% in 2022, then crashed by -162bps to 0.01% in 2023.
  • Business Quant data shows Return on Assets for CRBP at 0.01% in Q4 2023, 0.01% in Q3 2023, and 0.01% in Q2 2023.